Strategies For Engineered Negligible Senescence

SENS is an acronym that stands for "strategies for engineered negligible senescence," and it refers to a group of regenerative medical treatments that are either planned or already in development with the goal of repairing all age-related damage to human tissue on a periodic basis. These treatments are being developed with the ultimate goal of keeping patients in a condition of minimal senescence and delaying the onset of age-related diseases. Aubrey de Grey, a British biogerontologist, was the one who initially coined the term SENS.

How You Will Benefit

(I) Insights, and validations about the following topics:

Chapter 1: Strategies for engineered negligible senescence

Chapter 2: Life extension

Chapter 3: Gerontology

Chapter 4: Aubrey de Grey

Chapter 5: Biogerontology

Chapter 6: Rejuvenation

Chapter 7: Index of topics related to life extension

Chapter 8: Rejuvenation Research

Chapter 9: Outline of life extension

Chapter 10: Preston Estep

Chapter 11: Suresh Rattan

Chapter 12: Aging-associated diseases

Chapter 13: Longevity escape velocity

Chapter 14: Methuselah Foundation

Chapter 15: Ending Aging

Chapter 16: Pro-aging trance

Chapter 17: SENS Research Foundation

Chapter 18: Anti-aging movement

Chapter 19: Senolytic

Chapter 20: Societal effects of negligible senescence

Chapter 21: Timeline of senescence research

(II) Answering the public top questions about strategies for engineered negligible senescence.

(III) Real world examples for the usage of strategies for engineered negligible senescence in many fields.

(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of strategies for engineered negligible senescence' technologies.

Who This Book Is For

Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of strategies for engineered negligible senescence.